Oohira A, Nogami H
Department of Embryology, Institute for Developmental Research, Kasugai, Japan.
Bone. 1989;10(6):409-13. doi: 10.1016/8756-3282(89)90071-9.
The content and composition of glycosaminoglycans in the tubular bones of osteogenesis imperfecta were compared to those in the tubular bones of age-matched controls. Chondroitin sulfate was the major glycosaminoglycan (70-80% of total) both in the normal and pathological bones, and its level, based on the tissue wet weight, was slightly less in the pathological bones. The composition of chondroitin sulfate disaccharide units in the pathological samples was different from those of the control; a lower proportion of chondroitin 4-sulfate unit. Hyaluronate accounted for at most 7% of total glycosaminoglycans from the normal bones. The hyaluronate content of the pathological bones was 1.5- to 3-fold higher than that of the controls. Glycosaminoglycans have been shown to participate in the formation of a functional supramolecular complex in extracellular matrices. Therefore, it may be postulated that the abnormalities in glycosaminoglycan composition in the tubular bones of osteogenesis imperfecta is implicated in some clinical aspects of this connective tissue disorder such as the bony fragility.
将成骨不全症患者管状骨中糖胺聚糖的含量和组成与年龄匹配的对照组管状骨中的进行了比较。硫酸软骨素是正常骨和病理骨中主要的糖胺聚糖(占总量的70 - 80%),基于组织湿重,其在病理骨中的含量略低。病理样本中硫酸软骨素二糖单位的组成与对照组不同;硫酸软骨素4 - 硫酸酯单位的比例较低。透明质酸在正常骨的总糖胺聚糖中最多占7%。病理骨的透明质酸含量比对照组高1.5至3倍。糖胺聚糖已被证明参与细胞外基质中功能性超分子复合物的形成。因此,可以推测成骨不全症患者管状骨中糖胺聚糖组成的异常与这种结缔组织疾病的某些临床方面有关,如骨脆性。